Abbott gets CDSCO panel nod for importing, marketing of Estradiol, Dydrogesterone FDC Medical Dialogues Team11 July 2021 5:00 AM GMTNew Delhi: Approving Phase III Clinical Trial (CT) waiver, the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organization...
Relugolix combo significantly reduces menstrual bleeding in uterine fibroids patients: NEJM Medha Baranwal18 Feb 2021 1:31 PM GMTUSA: Once-daily treatment with relugolix combination therapy (relugolix, estradiol and norethindrone acetate) significantly reduces menstrual bleeding...
